Barclays PLC Medpace Holdings, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 19,781 shares of MEDP stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,781

Previous 11,506 71.92%

Holding current value

$6.14 Million

Previous $4.74 Million 39.33%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$320.58 - $457.29 $2.65 Million - $3.78 Million	8,275 Added 71.92%	19,781 $6.6 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $7.3 Million - $8.33 Million	-19,634 Reduced 63.05%	11,506 $4.74 Million
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $1.06 Million - $1.54 Million	3,722 Added 13.58%	31,140 $12.6 Million
Q4 2023 Feb 15, 2024	BUY	$227.52 - $312.68 $2.39 Million - $3.29 Million	10,521 Added 62.27%	27,418 $8.4 Million
Q3 2023 Nov 07, 2023	SELL	$233.98 - $281.67 $1.77 Million - $2.14 Million	-7,583 Reduced 30.98%	16,897 $4.09 Million
Q2 2023 Aug 03, 2023	BUY	$187.26 - $240.17 $614,774 - $788,478	3,283 Added 15.49%	24,480 $5.88 Million
Q1 2023 May 04, 2023	BUY	$174.31 - $239.52 $272,795 - $374,848	1,565 Added 7.97%	21,197 $3.99 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $988,767 - $1.46 Million	-6,460 Reduced 24.76%	19,632 $4.17 Million
Q3 2022 Nov 03, 2022	BUY	$145.13 - $182.49 $2.17 Million - $2.73 Million	14,963 Added 134.45%	26,092 $4.1 Million
Q2 2022 Aug 12, 2022	SELL	$130.2 - $168.03 $1.16 Million - $1.49 Million	-8,893 Reduced 44.42%	11,129 $1.67 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $3.39 Million - $5.24 Million	-24,437 Reduced 54.97%	20,022 $3.28 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $3.31 Million - $4.13 Million	18,105 Added 68.7%	44,459 $9.68 Million
Q3 2021 Nov 09, 2021	BUY	$170.18 - $198.21 $330,149 - $384,527	1,940 Added 7.95%	26,354 $4.99 Million
Q2 2021 Aug 13, 2021	BUY	$158.62 - $194.3 $13,482 - $16,515	85 Added 0.35%	24,414 $4.31 Million
Q1 2021 May 13, 2021	SELL	$132.02 - $168.26 $2.2 Million - $2.81 Million	-16,679 Reduced 40.67%	24,329 $3.99 Million
Q4 2020 Feb 11, 2021	SELL	$109.38 - $149.19 $4.55 Million - $6.21 Million	-41,602 Reduced 50.36%	41,008 $5.71 Million
Q3 2020 Nov 12, 2020	BUY	$92.95 - $130.61 $3.81 Million - $5.36 Million	41,015 Added 98.61%	82,610 $9.23 Million
Q2 2020 Aug 12, 2020	BUY	$68.08 - $95.68 $143,648 - $201,884	2,110 Added 5.34%	41,595 $3.87 Million
Q1 2020 May 13, 2020	SELL	$61.71 - $101.95 $1.11 Million - $1.83 Million	-17,934 Reduced 31.23%	39,485 $2.9 Million
Q4 2019 Feb 10, 2020	BUY	$70.08 - $84.64 $1.03 Million - $1.24 Million	14,700 Added 34.41%	57,419 $4.83 Million
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $291,376 - $401,192	4,671 Added 12.28%	42,719 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $898,309 - $1.1 Million	16,747 Added 78.62%	38,048 $2.49 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $752,798 - $1.08 Million	-15,245 Reduced 41.71%	21,301 $1.26 Million
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $455,280 - $620,158	9,693 Added 36.1%	36,546 $1.93 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $289,472 - $426,611	6,693 Added 33.2%	26,853 $1.61 Million
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $1.04 Million - $1.39 Million	-30,601 Reduced 60.28%	20,160 $866,000
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $726,536 - $885,771	22,683 Added 80.79%	50,761 $1.77 Million
Q4 2017 Feb 14, 2018	SELL	$32.46 - $38.31 $136,007 - $160,518	-4,190 Reduced 12.99%	28,078 $1.02 Million
Q3 2017 Nov 14, 2017	BUY	$27.43 - $33.11 $885,111 - $1.07 Million	32,268	32,268 $1.03 Million

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account